Filed: 8/14/2024ACC: 0000950123-24-008730
📋 What this filing means
OMEGA FUND MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 11 equity positions with a total reported market value of $134.97M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
11
Positions
$134.97M
Total AUM (reported)
25.44M
Total Shares
Allocation by class
COMMON STOCK$95.82M71.0%
COMMON STOCK CLASS A$38.77M28.7%
WARRANT$382.6K0.3%
Portfolio Concentration
Top 3$98.71M73.1%
4–10$35.88M26.6%
11–25$382.6K0.3%
Top 3 weight
73.1%
Top 10 weight
99.7%
Voting Authority Distribution
Total shares with voting rights: 25.44M
Sole
Full voting authority
25.44M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole11
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings11
Rows:
Nuvation Bio
SOLEShares13.28M
TypeSH
Market value$38.77M
28.72%
Sole
13.28M
Shared
0.00
None
0.00
Lexeo Therapeutics
SOLEShares2.36M
TypeSH
Market value$37.79M
28.00%
Sole
2.36M
Shared
0.00
None
0.00
Replimune Group
SOLEShares2.46M
TypeSH
Market value$22.15M
16.41%
Sole
2.46M
Shared
0.00
None
0.00
enGene Holdings Inc.
SOLEShares1.08M
TypeSH
Market value$10.15M
7.52%
Sole
1.08M
Shared
0.00
None
0.00
Alumis Inc
SOLEShares653.23K
TypeSH
Market value$8.69M
6.44%
Sole
653.23K
Shared
0.00
None
0.00
Morphic Holding
SOLEShares159.85K
TypeSH
Market value$5.45M
4.03%
Sole
159.85K
Shared
0.00
None
0.00
Sana Biotechnology, Inc.
SOLEShares843.75K
TypeSH
Market value$4.61M
3.41%
Sole
843.75K
Shared
0.00
None
0.00
Ikena Oncology
SOLEShares2.25M
TypeSH
Market value$3.71M
2.75%
Sole
2.25M
Shared
0.00
None
0.00
Immunic Inc
SOLEShares1.79M
TypeSH
Market value$1.98M
1.47%
Sole
1.79M
Shared
0.00
None
0.00
Syros Pharmaceuticals
SOLEShares251.27K
TypeSH
Market value$1.30M
0.96%
Sole
251.27K
Shared
0.00
None
0.00
enGene Holdings Inc.
SOLEShares321.50K
TypeSH
Market value$382.6K
0.28%
Sole
321.50K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Nuvation BioSOLE | Common Stock Class A | 13.28M | SH | $38.77M 28.72% | 13.28M | 0.00 | 0.00 |
Lexeo TherapeuticsSOLE | Common Stock | 2.36M | SH | $37.79M 28.00% | 2.36M | 0.00 | 0.00 |
Replimune GroupSOLE | Common Stock | 2.46M | SH | $22.15M 16.41% | 2.46M | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Common Stock | 1.08M | SH | $10.15M 7.52% | 1.08M | 0.00 | 0.00 |
Alumis IncSOLE | Common Stock | 653.23K | SH | $8.69M 6.44% | 653.23K | 0.00 | 0.00 |
Morphic HoldingSOLE | Common Stock | 159.85K | SH | $5.45M 4.03% | 159.85K | 0.00 | 0.00 |
Sana Biotechnology, Inc.SOLE | Common Stock | 843.75K | SH | $4.61M 3.41% | 843.75K | 0.00 | 0.00 |
Ikena OncologySOLE | Common Stock | 2.25M | SH | $3.71M 2.75% | 2.25M | 0.00 | 0.00 |
Immunic IncSOLE | Common Stock | 1.79M | SH | $1.98M 1.47% | 1.79M | 0.00 | 0.00 |
Syros PharmaceuticalsSOLE | Common Stock | 251.27K | SH | $1.30M 0.96% | 251.27K | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Warrant | 321.50K | SH | $382.6K 0.28% | 321.50K | 0.00 | 0.00 |